MDPV: Difference between revisions

Line 6:

|

|}

'''Methylenedioxypyrovalerone''' (commonly known as '''MDPV''' or '''bath salts''') is a potent euphoric stimulant with a short history of human use. MDPV acts as a norepinephrine-dopamine reuptake inhibitor (NDRI) and possesses [[stimulant]] qualities. It was first developed in the 1960s by a team at Boehringer Ingelheim. MDPV remained an obscure stimulant until around 2004, when it was reportedly first sold as a [[designer drug]] available to the public. Products labeled as bath salts containing MDPV were previously sold as recreational drugs in gas stations and convenience stores in the United States, similar to the marketing strategy of Spice and K2 as incense.

'''Methylenedioxypyrovalerone''' (commonly known as '''MDPV''' or '''bath salts''') is a potent euphoric stimulant with a short history of human use. MDPV acts as a norepinephrine-dopamine reuptake inhibitor (NDRI) and possesses [[stimulant]] qualities. It was first developed in the 1960s by a team at Boehringer Ingelheim. MDPV remained an obscure stimulant until around 2004, when it was reportedly first sold as a [[designer drug]] available to the public. Products labeled as "bath salts" containing MDPV were previously sold as recreational drugs in gas stations and convenience stores in the United States, similar to the marketing strategy of [[Synthetic cannabinoids|Spice and K2]] as incense.

Historical reports show records of the preparation of MDPV for potential use as a CNS stimulant. It was claimed to have potential to be an alternative for racemic amphetamine and, although showing some desirable qualities such as reduced toxicity as compared to amphetamine, MDPV was not developed as a medicinal drug.<ref> MDPV Summary | http://www.who.int/medicines/areas/quality_safety/4_13_Review.pdf?ua=1</ref>

@@ Line 6: / Line 6: @@
 |
 |}
-'''Methylenedioxypyrovalerone''' (commonly known as '''MDPV''' or '''bath salts''') is a potent euphoric stimulant with a short history of human use. MDPV acts as a norepinephrine-dopamine reuptake inhibitor (NDRI) and possesses [[stimulant]] qualities. It was first developed in the 1960s by a team at Boehringer Ingelheim. MDPV remained an obscure stimulant until around 2004, when it was reportedly first sold as a [[designer drug]] available to the public. Products labeled as bath salts containing MDPV were previously sold as recreational drugs in gas stations and convenience stores in the United States, similar to the marketing strategy of Spice and K2 as incense.
+'''Methylenedioxypyrovalerone''' (commonly known as '''MDPV''' or '''bath salts''') is a potent euphoric stimulant with a short history of human use. MDPV acts as a norepinephrine-dopamine reuptake inhibitor (NDRI) and possesses [[stimulant]] qualities. It was first developed in the 1960s by a team at Boehringer Ingelheim. MDPV remained an obscure stimulant until around 2004, when it was reportedly first sold as a [[designer drug]] available to the public. Products labeled as "bath salts" containing MDPV were previously sold as recreational drugs in gas stations and convenience stores in the United States, similar to the marketing strategy of [[Synthetic cannabinoids|Spice and K2]] as incense.
 Historical reports show records of the preparation of MDPV for potential use as a CNS stimulant. It was claimed to have potential to be an alternative for racemic amphetamine and, although showing some desirable qualities such as reduced toxicity as compared to amphetamine, MDPV was not developed as a medicinal drug.<ref> MDPV Summary | http://www.who.int/medicines/areas/quality_safety/4_13_Review.pdf?ua=1</ref>